Healthcare -
Biotechnology - NASDAQ - US
$ 39.3
1.58 %
$ 11 B
Market Cap
22.33
P/E
EXEL - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss EXEL - Exelixis, Inc.
-1.35 M
LAST VALUE
69.54%
2 YEAR CAGR
-7.55%
5 YEAR CAGR
-27.25%
10 YEAR CAGR